1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole

GTC-013

Pharmaceutical Intermediates

1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole

CAS No.
110963-63-8
Catalogue ID
GTC-013

1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole, CAS 110963-63-8. Source-derived identification, physical data and applications are provided for catalogue reference; request the current specification, COA and SDS for the required grade.

Catalogue aliases / related identifiers

1-(2-ethoxyethyl)-2-(4-piperidinyl)-1H-benzimidazole; Bilastine intermediate; Bilastine Impurity 7

Supplied catalogue source: GTC-013 · Page 96

Reference data — confirm before ordering or use

The information below is a structured migration from the supplied catalogue snapshot. It is not a current product specification, COA or SDS. Confirm the actual supplier, grade, batch documents, classification, packing and destination requirements for your enquiry.


Basic Information

CAS No.110963-63-8
EC No.Not available
Linear FormulaC16H23N3O
Molecular Weight273.37
AppearanceOff-white to light brown solid
Melting PointNot available (typical reference)
Boiling point452 ± 40 °C (predicted, lit.)
Density1.18 g/mL (predicted, lit.)
SolubilitySoluble in organic solvents including DMSO, methanol, and dichloromethane; limited solubility in water
Storage ConditionsKeep in a tightly closed container at 2-8°C, protected from light
Chemical StructureMolecular Structure of 1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole

Key Applications

  • Pharmaceutical intermediate: Serves as a core building block in the synthesis of bilastine, a second-generation antihistamine active pharmaceutical ingredient, and an important component within Bilastine and specialty antihistamine intermediates for pharmaceutical development.

  • API intermediate: Enables attachment of the ethoxyethyl group to the benzimidazole-piperidine framework essential for bilastine structure, making it relevant to piperazine and piperidine intermediates in API synthesis.

  • Heterocyclic synthesis: Provides a functionalized benzimidazole scaffold for constructing complex nitrogen-heterocyclic systems in organic synthesis, especially among quinazolinone, benzimidazole and fused heterocycle intermediates.

  • Medicinal chemistry research: Applied in the preparation of analogs and derivatives for antihistamine and related therapeutic explorations.

  • Process development: Facilitates route evaluation and optimization for scalable production of high-purity pharmaceutical intermediates for API synthesis.


  • Consistent product quality: Purity and key parameters controlled via standard analytical methods to provide dependable performance in synthetic workflows.

  • Stable global supply: Robust supply arrangements ensure continuous availability from small research quantities to larger commercial needs.

  • SDS and COA support: Comprehensive SDS and COA documentation prepared and provided to meet quality and regulatory expectations.

  • Packaging and technical service: Packaging tailored in 1kg, 5kg, or 25kg options with suitable liners, supported by prompt technical discussions.

Before you order

Confirm the current commercial product record.

Include the required grade or purity, quantity, preferred packing, destination country/port and required document set.

  • 01Current specification
  • 02Batch or sample COA
  • 03Product- and supplier-specific SDS
  • 04Packing and shipping review
Request product review

INQUIRY

INQUIRY